Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data
- DOI
- 10.17605/osf.io/tnzqr
- Published
- 2026
- Container
- Not recorded
- Publisher
- OSF Registries
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/publicdomain/zero/1.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.17605/osf.io/tnzqr,
title = {Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data},
author = {Mukesh Kumar Sharma},
year = {2026},
doi = {10.17605/osf.io/tnzqr},
url = {https://doi.org/10.17605/osf.io/tnzqr}
}RIS
TY - JOUR TI - Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data AU - Mukesh Kumar Sharma PY - 2026 DO - 10.17605/osf.io/tnzqr UR - https://doi.org/10.17605/osf.io/tnzqr ER -
APA
Sharma, M. K. (2026). Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data. https://doi.org/10.17605/osf.io/tnzqr
Source records
- datacite · retrieved 2026-11-08T00:06:41.004Z